iRhythm Technologies to Participate in Upcoming Investor Conferences
Rhea-AI Summary
iRhythm Technologies (NASDAQ:IRTC), a digital health care company specializing in disease detection, prevention, and prediction solutions, has announced its management team's participation in three upcoming investor conferences in June 2025:
- William Blair 45th Annual Growth Stock Conference on June 4, 2025, at 2:00 PM CT
- Goldman Sachs 46th Annual Global Healthcare Conference on June 10, 2025, at 2:40 PM ET
- Truist Securities MedTech Conference on June 17, 2025, at 1:40 PM ET
Live and archived webcasts will be available on the company's investor website at investors.irhythmtech.com.
Positive
- None.
Negative
- None.
News Market Reaction – IRTC
In the trading session that priced this news, IRTC gained 1.84%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN FRANCISCO, May 21, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that its management team is scheduled to present at the following investor conferences.
- William Blair 45th Annual Growth Stock Conference on Wednesday, June 4, 2025, at 2:00 p.m. Central Time (12:00 p.m. Pacific Time)
- Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10, 2025, at 2:40 p.m. Eastern Time (11:40 a.m. Pacific Time)
- Truist Securities MedTech Conference on Tuesday, June 17, 2025, at 1:40 p.m. Eastern Time (10:40 a.m. Pacific Time)
Interested parties may access live and archived webcasts of the presentations on the “Events & Presentations” section of the company’s investor website at investors.irhythmtech.com.
About iRhythm Technologies, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all. For additional information about iRhythm, please visit its corporate website at irhythmtech.com.
Investor Contact
Stephanie Zhadkevich
investors@irhythmtech.com
Media Contact
Kassandra Perry
irhythm@highwirepr.com
